Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

TRVI Stock Forecast, Price Targets, Chart, Dividends & Analysis

Trevi Therapeutics Inc. logo

Trevi Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

3.01
 
USD
  
0.07
  
(2.21%)
Previous close: 2.945  Open: 2.99  Bid: 2.82  Ask: 3.11
52 week range    
0.97   
   4.00
Mkt Cap: 224 M  Avg Vol (90 Days): 350,924
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 4th November 2024

Stock Rankings

45
MarketXLS Rank
60
Value
38
Technical
39
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

TRVI Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock-2 M
AccruedPreferredStockDividends2 M
Basic EPS from continuing operations-1.81-1.49-0.45-0.29
Basic EPS total-1.81-1.49-0.45-0.29
Basic weighted shares outstanding12 M18 M23 M65 M99 M
Depreciation-39000.047000.050000.043000.081000.0
DepreciationAndAmortization-39000.047000.050000.043000.081000.0
Diluted EPS total-2.28-1.81-1.49-0.45-0.29
Diluted normalized net income/share-2.28-0.45-0.29
Diluted weighted shares outstanding12 M18 M65 M99 M
GainOnSaleOfSecurity-9000.082000.0-147000.0
GeneralAndAdministrativeExpense7 M10 M9 M10 M10 M
Income before tax-26 M-33 M-34 M-29 M-29 M
Income taxes-18000.0-18000.0-21000.0-36000.0-32000.0
Interest income577000.0178000.010000.02 M5 M
InterestExpenseNonOperating456000.01 M1 M391000.0
MiscOtherSpecialCharges-9000.0-375000.0289000.0469000.0
Net income from total operations-26 M-33 M-34 M-29 M-29 M
NetIncomeCommonStockholders-27 M-33 M-34 M-29 M-29 M
NetIncomeContinuousOperations-26 M-33 M-34 M-29 M-29 M
NetNonOperatingInterestIncomeExpense577000.0-278000.0-1 M577000.04 M
Normalized income-34 M-29 M
Operating income-27 M-32 M-32 M-30 M-34 M
Operating income before depreciation (EBITDA)-26 M-32 M-33 M-28 M-29 M
OperatingExpense27 M32 M32 M30 M34 M
Other income net9000.0293000.0-142000.0-469000.0
OtherGandA7 M10 M9 M10 M10 M
OtherOperatingExpenses123000.0323000.0
OtherunderPreferredStockDividend704000.0
PreferredStockDividends704000.0
Research & development expense19 M22 M23 M20 M24 M
ResearchExpense19 M22 M23 M20 M24 M
SalariesAndWages-1 M2 M3 M2 M2 M
Selling Gen & administrative expense7 M10 M9 M10 M10 M
Total Income available for interest expense (EBIT)-26 M-32 M-33 M-28 M-29 M
Total common shares outstanding18 M20 M31 M60 M
Total net income-26 M-33 M-34 M-29 M-29 M
Total ordinary shares73 M73 M73 M73 M73 M
TotalExpenses27 M32 M32 M30 M34 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University